Asymmetric Triphenylethylene-Based Hole Transporting Materials for Highly Efficient Perovskite Solar Cells

Molecular hole-transporting materials (HTMs) having triphenylethylene central core were designed, synthesized, and employed in perovskite solar cell (PSC) devices. The synthesized HTM derivatives were obtained in a two- or three-step synthetic procedure, and their characteristics were analyzed by various thermoanalytical, optical, photophysical, and photovoltaic techniques. The most efficient PSC device recorded a 23.43% power conversion efficiency. Furthermore, the longevity of the device employing V1509 HTM surpassed that of PSC with state-of-art spiro-OMeTAD as the reference HTM.

Synthesis of Triphenylethylene-Naphthalimide Conjugates as topoisomerase-IIα inhibitor and HSA binder

A series of triphenylethylene-naphthalimide (TPE-naph) conjugates was synthesized by a molecular hybridization technique, and their anticancer activity was evaluated in vitro on 60 human cancer cell lines through their cytotoxicity. The ratios of E and Z isomers were determined on the basis of HPLC methodology and NMR spectroscopy. The structure-activity relationship for anticancer activity was deduced on the basis of the nature and bulkiness of the amine attached to the C-4 position of the naphthalene ring. Experimental and molecular modeling studies of the most active TPE-naph conjugate bearing a morpholinyl group showed that it was able to inhibit topoisomerase-II (TOPO-II) as a possible intracellular target. Moreover, the transportation behavior of TPE-naph conjugate towards human serum albumin (HSA) indicated efficient binding affinity. The steady-state and time-dependent fluorescent results suggested that this conjugate quenched HSA significantly through static as well as dynamic quenching. Thus, this report discloses the scope of triphenylethylene-naphthalimide (TPE-naph) conjugates as efficient anticancer agents.

Synthesis of novel flexible tamoxifen analogues to overcome CYP2D6 polymorphism and their biological evaluation on MCF-7 cell line

Tamoxifen (TAM) is currently the endocrine treatment of choice for all stages of breast cancer; it has proven success in ER positive and ER negative patients. TAM is activated by endogenous CYP450 enzymes to the more biologically active metabolites 4-hydroxytamoxifen and endoxifen mainly via CYP2D6 and CYP3A4/5. CYP2D6 has been investigated for polymorphism; there is a large interindividual variation in the enzyme activity, this drastically effects clinical outcomes of tamoxifen treatment. Here in we report the design and synthesis of 10 novel compounds bearing a modified tamoxifen skeleton, ring C is substituted with different ester groups to bypass the CYP2D6 enzyme metabolism and employ esterase enzymes for activation. All compounds endorse flexibility on ring A. Compounds (II-X) showed MCF-7% growth inhibition >50% at a screening dose of 10 μM. These results were validated by yeast estrogen screen (YES) and E-Screen assay combined with XTT assay. Compound II (E/Z 4-[1-4-(3-Dimethylamino-propoxy)-phenyl)-3-(4-methoxy-phenyl)-2-methyl-propenyl]-phenol) showed nanomolar antiestrogenic activity (IC₅₀ = 510 nM in YES assay) and was five times more potent in inhibiting the growth of MCF-7 BUS (IC₅₀ = 96 nM) compared to TAM (IC₅₀ = 503 nM). Esterified analogues VI, VII were three times more active than TAM on MCF-7 BUS (IC₅₀ = 167 nM). Novel analogues are prodrugs that can ensure equal clinical outcomes to all breast cancer patients.

Design, Synthesis, and Electrofluorochromism of New Triphenylamine Derivatives with AIE-Active Pendent Groups

Triphenylamine (TPA) and 4,4'-dimethoxy-triphenylamine (TPAOMe) derivatives were successfully linked with two high-performance AIEgens, triphenylethylene (TPE) and benzo[ b]thiophene-1,1-dioxide (BTO), to obtain four aggregation-induced emission and electro-active materials, TPETPA, BTOTPA, TPETPAOMe, and BTOTPAOMe. The effects on photoluminescence characteristics and electrochromic (EC) and electrofluorochromic (EFC) behaviors in cross-linking gel-type devices derived from the prepared materials were systematically investigated. Furthermore, heptyl viologen was introduced into the EFC devices to enhance EC performance including lower working potential, faster switching time, and superior stability.